Search

everythinglearnresearchcommunity

for

Search:↓

RHUPUS should be considered in children with deforming arthritis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Neonatal lupus symptoms usually resolve, but some children may develop other autoimmune diseases later.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

A small forehead lesion led to the discovery of a significant brain arteriovenous malformation in a young girl.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.